Why three Nordic countries have suspended Moderna vaccine

On October 6, Sweden and Denmark, followed by Finland a day later, suspended the use of Moderna’s mRNA vaccine for younger age groups after reports pointed to an increase in the number of myocarditis and pericarditis cases. Why three Nordic countries have suspended Moderna vaccine. On October 6, Sweden and Denmark suspended the use of … Continue reading Why three Nordic countries have suspended Moderna vaccine

Advertisement

A case of coronavirus reinfection in Hong Kong confirmed by genome sequencing

Using genome sequencing, researchers at the University of Hong Kong have found a rare instance of reinfection with novel coronavirus for the second time, four-and-a-half months after the first infection. The first viral genome belongs to GISAID clade V, while the second genome belongs to GISAID clade G. Using genome sequencing, researchers at the University … Continue reading A case of coronavirus reinfection in Hong Kong confirmed by genome sequencing

Coronavirus: Fewer infected people account for larger virus spread

Three studies have found that a small percentage of people who have been infected with novel coronavirus account for a large proportion of novel coronavirus spread, much above the expected average. These are called “superspreading events. Three different studies using very different methods and patient cohorts have found that a small percentage of people who … Continue reading Coronavirus: Fewer infected people account for larger virus spread

Faeces samples can harbour infectious coronavirus, study finds

Chinese researchers were able to isolate and culture novel coronavirus from faeces samples. Confirmation of infectious virus in faeces samples raises the potential for faecal-oral or faecal-respiratory transmission. During 2002 SARS, 329 residents of a private housing estate in Hong Kong were infected and 42 died due to aerosolised faeces spread of the virus. Researchers … Continue reading Faeces samples can harbour infectious coronavirus, study finds

Phase-2 trial: A three-drug regimen clears coronavirus in seven days

A phase-2 trial found that COVID-19 patients with mild to moderate illness had no detectable virus seven days after treatment with a three-drug regimen — oral lopinavir-ritonavir, ribavirin and injectable interferon beta-1b. The control group took 12 days to clear the virus. A phase-2 trial involving participants with mild to moderate COVID-19 illness found no detectable virus … Continue reading Phase-2 trial: A three-drug regimen clears coronavirus in seven days